ProCE Banner Activity

Chronic Spontaneous Urticaria: Key Concepts in Diagnosis and Treatment

Clinical Thought

Chronic spontaneous urticaria (CSU) significantly impacts a patient’s physical and emotional health, and appropriate management is essential for improving quality of life.In this expert commentary, Jonathan A. Bernstein, MD provides an overview of key concepts regarding the diagnosis and treatment CSU.

Released: September 15, 2022

Share

Faculty

Jonathan A. Bernstein

Jonathan A. Bernstein, MD

Adjunct Professor of Medicine
Department of Internal Medicine
Division of Rheumatology, Allergy and Immunology
Director of the University of Cincinnati Allergy and Research Laboratory and Allergy Clinical Trials
Partner of Advanced Allergy Services
Partner of Bernstein Clinical Research Center
Cincinnati, Ohio

Provided by

ProCE Banner
ProCE Banner

Supporters

Supported by educational grants from Novartis Pharmaceuticals Corporation and Sanofi and Regeneron Pharmaceuticals.

Novartis Pharmaceuticals Corporation

Sanofi and Regeneron Pharmaceuticals

Target Audience

Dermatologists and APPs and nurses who practice in dermatology.

Disclosure

Jonathan A. Bernstein, MD: consultant/advisor/speaker: AstraZeneca, Genentech, Novartis, Sanofi-Regeneron; research support: Allakos, AstraZeneca, Amgen, Celldex, Genentech, Sanofi-Regeneron, TLL.

Format

ClinicalThought

Additional Information

Program Medium

This program has been made available online.